Individual and Community-Level Social Determinant Associations with Skull Base Chordoma and Chondrosarcoma Disparities in the United States

美国颅底脊索瘤和软骨肉瘤差异与个人和社区层面的社会决定因素关联

阅读:1

Abstract

OBJECTIVE: Using multivariate models of social determinants of health (SDoH) featuring census-level Yost Index-socioeconomic status (SES) measures, to determine whether community-level SDoH factors quantifiably influence skull base chordoma-chondrosarcoma disparities more than individual-level SDoH factors on care-prognostic differences nationally. DESIGN SETTING PARTICIPANTS: Retrospective cohort, skull base chordomas/chondrosarcoma patients diagnosed between 2010 and 2018 from SEER (Surveillance, Epidemiology, and End Results) were analyzed by multivariate, age-adjusted regressions and Cox proportional hazards models; covariates of sex, race-ethnicity, census-level rurality-urbanicity, census-level Yost-Index score (aggregating 7 SES-measures of education, income, housing). MAIN OUTCOME MEASURES: Mortality, late-staging, first-line/nonfirst-line treatment, delay-in-treatment. RESULTS: Across 1,530 skull base chordomas and chondrosarcomas, delay-of-treatment featured a markedly positive independent predictor of minority race/ethnicity (odds ratio [OR], 1.72; 95% confidence interval [CI], 1.27-1.34; p  < 0.001). Five-year all-cause mortality showed markedly positive predictors of male-sex (1.82; 1.30-2.56; p < 0.001), minority race/ethnicity (OR, 1.94; 95% CI, 1.32-2.87; p  = 0.001), and decreasing Yost-SES (OR, 1.61; 95% CI, 1.14-2.26; p  = 0.006). Three-year all-cause mortality featured markedly positive predictors of male-sex (OR, 1.82; 95% CI, 1.30-2.56; p  < 0.001) and minority race/ethnicity (OR, 1.75; 95% CI, 1.18-2.58; p  = 0.005). Receipt of nonfirst-line radiation therapy showed a markedly positive independent predictor of minority race/ethnicity (OR, 1.34; 95% CI, 1.06-1.71; p  = 0.016). Receipt of first-line primary surgery showed a markedly negative independent predictor of decreasing Yost-SES (OR, 0.71; 95% CI, 0.53-0.96; p  = 0.024). Advanced-staging showed a markedly positive independent predictor of decreasing Yost-SES (OR, 1.85; 95% CI, 1.19-2.89; p  = 0.006). CONCLUSION: Through interactional models of individual- and community-level social determinant factors, this study observed detrimental, interrelated SDoH associations with poorer care and prognosis of chordoma and chondrosarcoma patients while quantifiably delineating the strength of factor association with observed disparities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。